Characterization of patient perception of odor severity in hidradenitis suppurativa using TARGET-DERM HS.
Characterization of patient perception of odor severity in hidradenitis suppurativa using TARGET-DERM HS
Publications
Read more →
Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS.
Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS
Machine learning–based identification of moderate-to-severe atopic dermatitis in US patients using the TARGET-DERM AD registry.
Machine learning–based identification of moderate-to-severe atopic dermatitis in US patients using the TARGET-DERM AD registry
A comparison of stable vs progressive hidradenitis suppurativa: insights from TARGET-DERM HS.
A comparison of stable vs progressive hidradenitis suppurativa: insights from TARGET-DERM HS
The impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM.
The impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
30
Total Publications
5
Abstract / Manuscript
3
Oral Presentation
22
Poster Presentation
2026 · Poster Presentation · Poster Presentation · Dermatology
Characterization of patient perception of odor severity in hidradenitis suppurativa using TARGET-DERM HS.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
Machine learning–based identification of moderate-to-severe atopic dermatitis in US patients using the TARGET-DERM AD registry.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
A comparison of stable vs progressive hidradenitis suppurativa: insights from TARGET-DERM HS.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
The impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
Real world characteristics and burden of patients initiating advanced systemic therapy in the TARGET-DERM atopic dermatitis registry.
Read more →2025 · Poster Presentation · Poster Presentation · Dermatology
Correlation between achieving SALT 20 score and clinician- and patient-reported outcomes among patients diagnosed with alopecia areata in the US: An assessment from the TARGET-DERM AA registry.
Read more →2025 · Poster Presentation · Poster Presentation · Dermatology
Race and ethnicity sub-groups of alopecia areata patients have differing clinical characteristics: TARGET-DERM AA.
Read more →2025 · Poster Presentation · Poster Presentation · Dermatology
Generic vs. disease-specific patient reported outcome (PRO) instruments for assessing HRQoL burden among patients diagnosed with alopecia areata: Evidence from TARGET-DERM AA.
Read more →2025 · Abstract / Manuscript · Abstract / Manuscript
Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry.
Read more →2024 · Poster Presentation · Poster Presentation · Dermatology
Demographics and disease characteristics of patients with alopecia areata with comorbid atopic dermatitis, vitiligo or anxiety/depression: TARGET-DERM AA.
Read more →2024 · Poster Presentation · Poster Presentation · Dermatology
Why Do Optimal Targets for Itch and Skin Clearance Matter in Atopic Dermatitis Treatment? Insights from the TARGET-DERM AD Registry.
Read more →2024 · Poster Presentation · Poster Presentation · Dermatology
Real-world study of hidradenitis suppurativa: skin lesions and pain are associated with Hurley Stage in TARGET-DERM HS.
Read more →2024 · Abstract / Manuscript · Abstract / Manuscript
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry.
Read more →2024 · Oral Presentation · Oral Presentation · Dermatology
Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA.
Read more →2024 · Poster Presentation · Approval / Commercialization · Dermatology
Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from the TARGET-DERM AD registry.
Read more →2023 · Poster Presentation · Approval / Commercialization · Dermatology
Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from TARGET-DERM registry.
Read more →2023 · Poster Presentation · Care · Dermatology
Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry.
Read more →2023 · Poster Presentation · Poster Presentation · Dermatology
The role of itch resolution and skin clearance in patient-reported atopic dermatitis severity and quality of life: Real-world Insights from TARGET-DERM AD.
Read more →2023 · Oral Presentation · Care · Dermatology
Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry.
Read more →2023 · Oral Presentation · Care · Dermatology
Unmet Needs of Adolescents with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry.
Read more →2022 · Poster Presentation · Care · Dermatology
Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: A Cross Sectional Study from the TARGET-DERM AD Cohort.
Read more →2022 · Poster Presentation · Care · Dermatology
Use of Advanced Systemic Therapy in Patients with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry.
Read more →2022 · Abstract / Manuscript · Abstract / Manuscript
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort.
Read more →2022 · Poster Presentation · Poster Presentation · Dermatology
Healthcare Disparities in Atopic Dermatitis: Insights from TARGET DERM Registry.
Read more →2021 · Poster Presentation · Care · Dermatology
Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: a Cross Sectional Study from the TARGET-DERM AD Cohort.
Read more →2021 · Poster Presentation · Care · Dermatology
Burden of Disease is Positively Associated with Disease Severity in Atopic Dermatitis.
Read more →2020 · Poster Presentation · Poster Presentation · Dermatology